DEA Archived Press Releases

Press Releases before January 20, 2025
60 Results - Showing 1 to 10
PRESS RELEASE

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

WASHINGTON - The United States Drug Enforcement (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances (CSA) for those who are conducting FDA-approved clinical trials on (CBD), an extract of the marijuana plant. These modifications will streamline the research process regarding CBD’s possible medicinal value and...
PRESS RELEASE

DEA Announces “360 Strategy” To Address Heroin, Prescription Drugs And Violent Crime

PITTSBURGH - The United States Drug Enforcement Administration today announced Pittsburgh as the pilot city for a comprehensive law enforcement and prevention “360 Strategy” to help cities dealing with a heroin and prescription drug abuse epidemic, and its associated violent crime. DEA Special Agent in Charge for the Philadelphia Division...
PRESS RELEASE

Twelve Arrested In Major Meth & Heroin Trafficking Organization

SEATTLE - - A two year investigation of a major drug trafficking ring in King and Snohomish counties culminated in 12 arrests today following the unsealing of a grand jury indictment and filing of criminal complaints against two dozen defendants. Over the two years of the Drug Enforcement Administration led...
PRESS RELEASE

DEA Releases 2015 Drug Threat Assessment: Heroin And Painkiller Abuse Continue To Concern

WASHINGTON - DEA Acting Administrator Chuck Rosenberg today announced results from the 2015 National Drug Threat (NDTA), which found that drug overdose deaths are the leading cause of injury death in the United States, ahead of deaths from motor vehicle accidents and firearms. In 2013, more than 46,000 people in...
PRESS RELEASE

151 Arrested In DEA-Led Investigation Of Synthetic Drug Rings

WASHINGTON - The Drug Enforcement (DEA), Immigration and Customs (ICE) Homeland Security (HSI), Customs and Border (CBP), along with other federal, state, and local law enforcement today concluded a 15-month, nationwide drug interdiction effort that resulted in 151 arrests in 16 states. The enforcement action, known as Project Synergy III...
PRESS RELEASE

DEA’S Prescription Drug Take-Back Effort-- A Big Success

WASHINGTON - Thousands of Americans in communities across the country discarded more than 350 tons of unused, expired, or unwanted drugs as part of the Drug Enforcement Administration’(DEA) National Prescription Drug Take-Back Day (NTBI) on Saturday, September 26. This past weekend, more than 3,800 federal, state and local counterparts took...
PRESS RELEASE

The Pacific Northwest Responds To Prescription Drug “Take-Back” With Record Collection

SEATTLE - -Residents of the Pacific (PNW) responded overwhelmingly to the most recent DEA National Prescription Drug Take Back Day. On September 26th, 2015, in a four hour period, residents of Washington, Oregon, Idaho and Alaska combined, turned in a record breaking 33,919 (17 tons) of unwanted or expired medications...
PRESS RELEASE

Four Suspects Charged In Marijuana Grow Operation Concealed Within Boise County’s Forest Land

BOISE, Idaho - - Carlos Avalos-Cervantes, 30, and Martin Diaz-Lara, 26, both Mexican nationals currently living in Walla Walla, Washington, were arrested in the remote mountain area early in the morning on September 23, 2015, on charges of conspiracy and manufacturing with intent to distribute marijuana, possession of firearms in...
PRESS RELEASE

Ketchikan Residents Sentenced To Prison For Trafficking Methamphetamine And Heroin

ANCHORAGE, Alaska - - Robert Duane Moriarty, 36, and Sara Skan, 35, of Ketchikan, Alaska, were sentenced today in Juneau by U.S. District Court Judge Timothy M. Burgess. Moriarity received a sentence of 60 months of imprisonment followed by a five year term of supervised release, and Skan received 18...
PRESS RELEASE

DEA Dialogues With Registrants On Preventing Pharmaceutical Diversion At Conference This Week

WASHINGTON - The new head of the U.S. Drug Enforcement Administration’(DEA’s) Office of Diversion Control met with the agency’s registered pharmaceutical manufacturers, importers, and exporters this week to discuss how they can prevent pharmaceutical diversion while minimizing the impact on legitimate commerce. Almost 300 registrants attended the conference held September...